Health Care

Commentary

Trump Takes Aim Hospitals’ Pricey Lack of Transparency

Americans typically know the price of a television, refrigerator, or airline ticket before they buy it. But when it comes to hospital care, many don’t learn the cost until the bill arrives. The Trump administration is trying to change that. Earlier this month, federal regulators put more than 500 hospitals ...
340B

Dr. Wayne Winegarden featured in Golden State Today: 340B Transparency is “Nonexistent”

California economist: ‘The transparency is nonexistent’ in federal 340b drug discount program By A. R. Baird A California healthcare economist is calling for greater transparency in the federal 340B Drug Pricing Program, arguing that lawmakers, taxpayers and even participating hospitals lack sufficient reporting to determine whether billions of dollars in ...
340B

Listen to Wayne Winegarden on the Health Policy Podcast: The $100 Billion Loophole: Why 340B Reform is Essential

In the Health Policy Podcast episode featuring Wayne Winegarden from the Pacific Research Institute, the discussion centers on the 340B Drug Pricing Program. Winegarden critiques the program’s lack of transparency and its unintended consequences, which have led to large hospital systems profiting at the expense of smaller institutions and patients. ...
Commentary

Trump Takes Aim Hospitals’ Pricey Lack of Transparency

Earlier this month, federal regulators put more than 500 hospitals on notice for failing to properly disclose what they charge for common procedures and services. The warnings are the latest step in President Trump’s long-running effort to bring greater price transparency to healthcare. It’s a fight worth having. Click to ...
Commentary

Healthcare costs keep rising. Hospitals are a big reason why.

Congress recently hauled CEOs from some of the nation’s largest hospital systems to Capitol Hill to answer for America’s soaring healthcare costs. And lawmakers didn’t pull their punches. House Ways and Means Chairman Jason Smith, R-Mo., accused hospitals of building “empires” and told executives that the prices they charge patients ...
Commentary

The Real Lesson Of America’s Rising Uninsured Rate

The number of uninsured Americans ticked upward to 26.7 million in 2024, according to an analysis published this month by KFF. The report’s authors attribute that trend to the “high cost of private insurance and limited availability of public coverage.” Unpack the numbers, though, and the situation becomes more complicated. ...
Commentary

Healthcare costs keep rising. Hospitals are a big reason why.

House Ways and Means Chairman Jason Smith, R-Mo., accused hospitals of building “empires” and told executives that the prices they charge patients amount to “borderline extortion.” The hearing underscored a reality Washington has been slow to confront. Hospitals are the primary drivers of rising health costs. They are consolidating markets, ...
Commentary

Declining Obamacare enrollment isn’t the crisis critics claim

Enrollment in Obamacare’s exchange is falling, according to a new analysis from the Commonwealth Fund. The study suggests that the expiration of the enhanced premium subsidies enacted during the pandemic has made coverage unaffordable for many Americans. Some consumers undoubtedly have decided that exchange plans are no longer worth the ...
Commentary

No, Proving Medical Frailty Isn’t Too Much to Ask

The Trump administration just released a new rule making clear that Medicaid’s work requirements are just that — requirements. Beginning in 2027, able-bodied adults who gained Medicaid coverage through Obamacare’s expansion of the program will generally need to spend at least 80 hours per month working, studying, participating in job ...
Biosimilars

PBM’s Drug Cut Exceeds the Total Cost of Medicines In Most Other Countries

Another fundamental problem is these comparisons rely on U.S. medicines’ gross (or list) price. But list prices do not account for the complex U.S. drug supply chain, where manufacturers receive only a portion of the gross price and intermediaries, such as pharmacy benefit managers (PBMs), receive a disproportionate share. As ...
Commentary

Trump Takes Aim Hospitals’ Pricey Lack of Transparency

Americans typically know the price of a television, refrigerator, or airline ticket before they buy it. But when it comes to hospital care, many don’t learn the cost until the bill arrives. The Trump administration is trying to change that. Earlier this month, federal regulators put more than 500 hospitals ...
340B

Dr. Wayne Winegarden featured in Golden State Today: 340B Transparency is “Nonexistent”

California economist: ‘The transparency is nonexistent’ in federal 340b drug discount program By A. R. Baird A California healthcare economist is calling for greater transparency in the federal 340B Drug Pricing Program, arguing that lawmakers, taxpayers and even participating hospitals lack sufficient reporting to determine whether billions of dollars in ...
340B

Listen to Wayne Winegarden on the Health Policy Podcast: The $100 Billion Loophole: Why 340B Reform is Essential

In the Health Policy Podcast episode featuring Wayne Winegarden from the Pacific Research Institute, the discussion centers on the 340B Drug Pricing Program. Winegarden critiques the program’s lack of transparency and its unintended consequences, which have led to large hospital systems profiting at the expense of smaller institutions and patients. ...
Commentary

Trump Takes Aim Hospitals’ Pricey Lack of Transparency

Earlier this month, federal regulators put more than 500 hospitals on notice for failing to properly disclose what they charge for common procedures and services. The warnings are the latest step in President Trump’s long-running effort to bring greater price transparency to healthcare. It’s a fight worth having. Click to ...
Commentary

Healthcare costs keep rising. Hospitals are a big reason why.

Congress recently hauled CEOs from some of the nation’s largest hospital systems to Capitol Hill to answer for America’s soaring healthcare costs. And lawmakers didn’t pull their punches. House Ways and Means Chairman Jason Smith, R-Mo., accused hospitals of building “empires” and told executives that the prices they charge patients ...
Commentary

The Real Lesson Of America’s Rising Uninsured Rate

The number of uninsured Americans ticked upward to 26.7 million in 2024, according to an analysis published this month by KFF. The report’s authors attribute that trend to the “high cost of private insurance and limited availability of public coverage.” Unpack the numbers, though, and the situation becomes more complicated. ...
Commentary

Healthcare costs keep rising. Hospitals are a big reason why.

House Ways and Means Chairman Jason Smith, R-Mo., accused hospitals of building “empires” and told executives that the prices they charge patients amount to “borderline extortion.” The hearing underscored a reality Washington has been slow to confront. Hospitals are the primary drivers of rising health costs. They are consolidating markets, ...
Commentary

Declining Obamacare enrollment isn’t the crisis critics claim

Enrollment in Obamacare’s exchange is falling, according to a new analysis from the Commonwealth Fund. The study suggests that the expiration of the enhanced premium subsidies enacted during the pandemic has made coverage unaffordable for many Americans. Some consumers undoubtedly have decided that exchange plans are no longer worth the ...
Commentary

No, Proving Medical Frailty Isn’t Too Much to Ask

The Trump administration just released a new rule making clear that Medicaid’s work requirements are just that — requirements. Beginning in 2027, able-bodied adults who gained Medicaid coverage through Obamacare’s expansion of the program will generally need to spend at least 80 hours per month working, studying, participating in job ...
Biosimilars

PBM’s Drug Cut Exceeds the Total Cost of Medicines In Most Other Countries

Another fundamental problem is these comparisons rely on U.S. medicines’ gross (or list) price. But list prices do not account for the complex U.S. drug supply chain, where manufacturers receive only a portion of the gross price and intermediaries, such as pharmacy benefit managers (PBMs), receive a disproportionate share. As ...
Scroll to Top